|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:KANK2-CGGBP1 (FusionGDB2 ID:41108) |
Fusion Gene Summary for KANK2-CGGBP1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: KANK2-CGGBP1 | Fusion gene ID: 41108 | Hgene | Tgene | Gene symbol | KANK2 | CGGBP1 | Gene ID | 25959 | 8545 |
| Gene name | KN motif and ankyrin repeat domains 2 | CGG triplet repeat binding protein 1 | |
| Synonyms | ANKRD25|MXRA3|NPHS16|PPKWH|SIP | CGGBP|p20-CGGBP | |
| Cytomap | 19p13.2 | 3p11.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | KN motif and ankyrin repeat domain-containing protein 2SRC-interacting proteinSRC1-interacting proteinankyrin repeat domain-containing protein 25kidney ankyrin repeat-containing protein 2matrix-remodeling-associated protein 3 | CGG triplet repeat-binding protein 120 kDa CGG-binding proteinCGG-binding protein 1p20-CGG binding proteinp20-CGGBP DNA-binding protein | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | Q63ZY3 | Q9UFW8 | |
| Ensembl transtripts involved in fusion gene | ENST00000355150, ENST00000432929, ENST00000586659, ENST00000587317, ENST00000589359, ENST00000589894, | ENST00000309534, ENST00000398392, ENST00000462901, ENST00000474441, ENST00000482016, | |
| Fusion gene scores | * DoF score | 3 X 2 X 2=12 | 3 X 3 X 1=9 |
| # samples | 3 | 3 | |
| ** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: KANK2 [Title/Abstract] AND CGGBP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | KANK2(11274946)-CGGBP1(88173941), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | KANK2 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 17476305 |
| Hgene | KANK2 | GO:0008285 | negative regulation of cell proliferation | 17476305 |
| Hgene | KANK2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 17476305 |
| Hgene | KANK2 | GO:0043069 | negative regulation of programmed cell death | 22371500 |
| Hgene | KANK2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 17476305 |
| Tgene | CGGBP1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10692448 |
| Fusion gene breakpoints across KANK2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across CGGBP1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | BI496580 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
Top |
Fusion Gene ORF analysis for KANK2-CGGBP1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000355150 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000355150 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000355150 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000355150 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000355150 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000432929 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000432929 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000432929 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000432929 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000432929 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000586659 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000586659 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000586659 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000586659 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| 5CDS-intron | ENST00000586659 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000587317 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000587317 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000587317 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000587317 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000587317 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589359 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589359 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589359 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589359 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589359 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589894 | ENST00000309534 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589894 | ENST00000398392 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589894 | ENST00000462901 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589894 | ENST00000474441 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| intron-intron | ENST00000589894 | ENST00000482016 | KANK2 | chr19 | 11274946 | - | CGGBP1 | chr3 | 88173941 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for KANK2-CGGBP1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for KANK2-CGGBP1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:11274946/:88173941) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| KANK2 | CGGBP1 |
| FUNCTION: Involved in transcription regulation by sequestering in the cytoplasm nuclear receptor coactivators such as NCOA1, NCOA2 and NCOA3 (PubMed:17476305). Involved in regulation of caspase-independent apoptosis by sequestering the proapoptotic factor AIFM1 in mitochondria (PubMed:22371500). Pro-apoptotic stimuli can induce its proteasomal degradation allowing the translocation of AIFM1 to the nucleus to induce apoptosis (PubMed:22371500). Involved in the negative control of vitamin D receptor signaling pathway (PubMed:24671081). Involved in actin stress fibers formation through its interaction with ARHGDIA and the regulation of the Rho signaling pathway (PubMed:17996375, PubMed:25961457). May thereby play a role in cell adhesion and migration, regulating for instance podocytes migration during development of the kidney (PubMed:25961457). Through the Rho signaling pathway may also regulate cell proliferation (By similarity). {ECO:0000250|UniProtKB:Q8BX02, ECO:0000269|PubMed:17476305, ECO:0000269|PubMed:17996375, ECO:0000269|PubMed:22371500, ECO:0000269|PubMed:24671081, ECO:0000269|PubMed:25961457}. | FUNCTION: Binds to nonmethylated 5'-d(CGG)(n)-3' trinucleotide repeats in the FMR1 promoter. May play a role in regulating FMR1 promoter. {ECO:0000269|PubMed:9201980}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for KANK2-CGGBP1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for KANK2-CGGBP1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for KANK2-CGGBP1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for KANK2-CGGBP1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies